지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.7
- 수록면
- 433 - 443 (11page)
- DOI
- 10.23876/j.krcp.23.321
이용수
초록· 키워드
오류제보하기
Background: Identifying risk factors and improving prognostication for mortality among patients with sepsis-associated acute kidney injury (AKI) undergoing continuous kidney replacement therapy (CKRT) is important in improving the adverse prognosis of this patient population. This study aimed to compare the prognostic value of existing systemic inflammation biomarkers and determine the optimal systemic inflammation biomarker in patients with sepsis-associated AKI receiving CKRT. Methods: This multi-center, retrospective, observational cohort study included 1,500 patients with sepsis-associated AKI treated with intensive care and CKRT. The main predictor was a panel of 13 different systemic inflammation biomarkers. The primary outcome was 28-day mortality after CKRT initiation. Secondary outcomes included 90-day mortality after CKRT initiation, CKRT duration, kidney replacement therapy dependence at discharge, and lengths of intensive care unit (ICU) and hospital stays. Results: When added to the widely accepted Acute Physiology and Chronic Health Evaluation II score, platelet-to-albumin ratio (PAR) and neutrophil-platelet score (NPS) had the highest improvements in prognostication of 28-day mortality, where the corresponding increases in C-statistic were 0.01 (95% confidence interval [CI], 0.00–0.02) and 0.02 (95% CI, 0.01–0.03). Similar findings were observed for 90-day mortality. The 28- and 90-day mortality rates were significantly lower for the higher PAR and NPS quartiles. These associations remained significant even after adjustment for potential confounding variables in multivariable Cox proportional hazards models. Conclusion: Of the available systemic inflammation biomarkers, the addition of PAR or NPS to conventional ICU prediction models improved the prognostication of patients with sepsis-associated AKI receiving intensive care and CKRT.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Plasma presepsin for mortality prediction in patients with sepsis-associated acute kidney injury requiring continuous kidney replacement therapy
Kidney Research and Clinical Practice
2024 .07
-
The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: a retrospective study on patient outcomes and safety
Kidney Research and Clinical Practice
2024 .07
-
Phosphate level predicts mortality in acute kidney injury patients undergoing continuous kidney replacement therapy and has a U-shaped association with mortality in patients with high disease severity: a multicenter retrospective study
Kidney Research and Clinical Practice
2024 .07
-
Biomarkers for Prediction of Mortality and Sepsis
대한외과학회 학술대회 초록집
2021 .11
-
Identification of Biomarkers for the Diagnosis of Sepsis-Associated Acute Kidney Injury and Prediction of Renal Recovery in the Intensive Care Unit
Yonsei Medical Journal
2023 .03
-
Mortality associated with the neutrophil-lymphocyte ratio in septic acute kidney injury requiring continuous renal replacement therapy
Kidney Research and Clinical Practice
2024 .05
-
COVID-19?induced acute kidney injury in critically ill patients: epidemiology, risk factors, and outcome
Acute and Critical Care
2021 .11
-
Comparison of Outcomes of Mild and Severe Community- and Hospital-Acquired Acute Kidney Injury
Yonsei Medical Journal
2022 .10
-
Clinical Significance of Acute Kidney Injury in Lung Cancer Patients
Cancer Research and Treatment
2021 .10
-
Acute kidney injury and mortality in coronavirus disease 2019: results from a cohort study of 1,280 patients
Kidney Research and Clinical Practice
2021 .01
-
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients
Kidney Research and Clinical Practice
2021 .01
-
Pyruvate Kinase M2 : A Novel Biomarker for the Early Detection of Acute Kidney Injury
Toxicological Research
2016 .01
-
Differences in the incidence, characteristics, and outcomes of patients with acute kidney injury in the medical and surgical intensive care units
Kidney Research and Clinical Practice
2024 .07
-
An Update on Sepsis Biomarkers
Infection and Chemotherapy
2020 .01
-
Acute kidney injury and continuous renal replacement therapy in children; what pediatricians need to know
Clinical and Experimental Pediatrics
2018 .01
-
Mortality of elderly patients with acute kidney injury undergoing continuous renal replacement therapy: is age a risk factor?
Kidney Research and Clinical Practice
2024 .07
-
Mortality difference between early-identified sepsis and late-identified sepsis
Clinical and Experimental Emergency Medicine
2020 .01
-
Association between volume status assessed by bioelectrical impedance analysis, lung ultrasound, or weight change and mortality in patients with sepsis-associated acute kidney injury receiving continuous kidney replacement therapy
Kidney Research and Clinical Practice
2024 .01
-
Application of Sepsis-3 Criteria to Korean Patients with Critical Illnesses
Acute and Critical Care
2019 .01
-
Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs
Kidney Research and Clinical Practice
2024 .07
최근 본 자료
댓글(0)
0